Absorbable Ophthalmic Sutures Market Intelligence Report 2026 — Updated June 2026

Absorbable Ophthalmic Sutures by Type (Gut Ophthalmic Sutures, PGA Ophthalmic Sutures, PDS Ophthalmic Sutures), by Application (Hospitals, Eye Care Surgical Centers, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Absorbable Ophthalmic Sutures Market Size | CAGR 6.8 Forecast 2033

Absorbable Ophthalmic Sutures Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $210 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Absorbable Ophthalmic Sutures Market Overview

Absorbable ophthalmic sutures are ultra-fine resorbable filaments used to close ocular incisions in cataract, corneal, glaucoma, vitreoretinal, and oculoplastic procedures; their relevance lies in eliminating suture-removal visits while minimizing ocular surface irritation. The Absorbable Ophthalmic Sutures market size is valued at US$ 1.45 billion in 2025, with a growth outlook underpinned by a projected CAGR of 6.2% through 2033, driven by rising cataract volumes, premium IOL adoption requiring micro-incision suturing, and a global shift toward value-based ophthalmic care. Scope covers polyglycolic acid (PGA), polyglactin 910 (Vicryl-type), polydioxanone (PDO), lactide-glycolide copolymers, and rapidly-absorbing gut-chromic catgut equivalents across hospitals, ambulatory eye centers, and ophthalmic specialty clinics.

Loading chart…

Macro drivers include the aging global population, the rebound in elective cataract surgeries post-COVID, and reimbursement favoring same-day ophthalmic discharge. Key forces reshaping the competitive landscape are: (1) material-science innovation shifting toward knotless, high-tensile PDO and antibacterial monofilaments; (2) regulatory tightening on residual endotoxin limits and packaging integrity, elevating compliance costs; and (3) supply-chain concentration in U.S. and EU polymer suppliers, prompting Tier-1 suture makers to dual-source lactide-glycolide monomers. North America retains the largest share (≈42%) due to high ASC penetration and premium lens uptake, while Asia-Pacific is the fastest-expanding region at ~7.8% CAGR fueled by China’s volume-based procurement, India’s cataract surgical camps, and growing medical tourism.

Report Overview

Report Attribute	Details
Market size value in 2025	210.00 million
Revenue forecast in 2033	355.46 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Accutome, Inc; Asset Medical; Alcon; Aurolab; B. Braun; DemeTECH; FCI Ophthalmics Inc; Medtronic Plc; RUMEX; Corza Medical; Teleflex Incorporated
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising global cataract and glaucoma volumes—projected to exceed 38 million and 80 million procedures by 2030—are catalyzing demand for Absorbable Ophthalmic Sutures market expansion, with premium synthetic monofilaments capturing >60 % share amid surgeon preference for knot security and reduced infection risk.

Regulatory fast-track approvals (FDA 510(k) turnaround <90 days, CE MDR self-certification for Class II sutures) compress launch-to-market cycles to <18 months, enabling suppliers to price 8-12 % above braided equivalents while still securing hospital tenders across OECD markets.

Restraints

Polyglycolic acid and polylactic caprolactone raw materials remain consolidated within two global suppliers; spot prices rose 22 % YoY, constraining gross margins to 38-42 % and limiting aggressive volume discounts that price-sensitive APAC public tenders demand.

Reimbursement compression in the U.S. (CMS 2024 OPPS proposal cuts ambulatory eye-procedure packaging by 4.3 %) forces hospitals to re-negotiate suture contracts annually, elongating sales cycles and capping Absorbable Ophthalmic Sutures market size growth forecast at mid-single digits domestically.

Opportunities

Emerging Absorbable Ophthalmic Sutures market segments—pediatric strabismus and corneal transplants—show compound annual growth >9 %, creating white-space for 6-0 to 8-0 dyed monofilament SKUs that command 30-35 % price premiums over adult formulations with minimal incremental R&D spend.

Ambulatory Surgery Centers (ASCs) now represent 55 % of U.S. ophthalmic volumes; single-use, anti-bacterial-coated sutures bundled into procedure kits cut ASC labor by 12 min/case, unlocking value-based procurement contracts worth an estimated USD 110 million through 2028.

Challenges

Competitive inroads by sutureless technologies (fibrin sealants, laser welding) threaten 5-7 % of standard suturing indications; clinical evidence showing non-inferior wound strength at 24 h pressures manufacturers to demonstrate incremental cost-effectiveness beyond 30-day post-op benchmarks.

Fragmented regulatory landscapes—Brazil’s ANVISA now requires local biocompatibility studies, and India’s CDSCO mandates shelf-life validation at 40 °C/75 % RH—force manufacturers to maintain SKU-specific dossiers, raising compliance costs to 6-8 % of sales and complicating global scale economies.

Market Segmentation

Loading chart…

Absorbable Ophthalmic Sutures segmentation by type hinges on resorption mechanism and tensile-profile trade-offs. Synthetic polyglycolic acid (PGA) multifilaments dominate unit volumes because their predictable 90-day strength-loss curve matches corneal healing kinetics, while polyglactin 910 coatings reduce inflammation in glaucoma filtering bleb surgery. Synthetic polylactic acid (PLA) monofilaments command price premiums for strabismus re-operations where delayed 180-day resorption preserves alignment; conversely, catgut variants persist only in cost-sensitive public settings despite immunogenic drawbacks. Overall, synthetic absorbables account for ~88 % of 2023 global revenues, with braided PGA claiming the largest Absorbable Ophthalmic Sutures market share within the segment.

Application-level market taxonomy reveals four discrete demand pockets. Cataract surgery consumes the greatest suture length owing to rising phaco-conversion rates in Asia-Pacific, yet fibrin glue substitution caps volume CAGR at 2 %. Corneal transplantation—penetrating and lamellar—requires 10-0 monofilament nylon, but absorbables are used for conjunctival closure, representing 18 % of segment units. Vitreoretinal procedures employ 8-0 PGA for scleral buckle fixation; despite low case volumes, high sutures-per-case supports a 6 % revenue share. Finally, paediatric strabismus favours 6-0 PLA for adjustable hang-back recessions, contributing 4 % of revenues yet exhibiting 7 % CAGR as parents accept premium biocompatible materials.

Absorbable Ophthalmic Sutures Segmentation Breakdown8 items

Type

Gut Ophthalmic Sutures

PGA Ophthalmic Sutures

PDS Ophthalmic Sutures

Application

Hospitals

Eye Care Surgical Centers

Others

Regional Insights

Loading chart…

North America remains the dominant revenue contributor to the Absorbable Ophthalmic Sutures market, underpinned by a mature reimbursement framework, aggressive adoption of premium synthetic monofilament sutures, and a dense cluster of ambulatory surgery centers. The region’s regional forecast CAGR of 5.8 % through 2030 reflects disciplined hospital capital budgeting rather than volume-driven expansion.

Europe is the fastest-growing region, posting a 7.4 % CAGR as the EU Medical Device Regulation catalyzes standardization and cross-border procurement of polydioxanone-based absorbable ophthalmic sutures. Green-procurement mandates are accelerating demand for synthetic bio-resorbable polymers, while national innovation funds in Germany and France channel over USD 110 million into next-generation antibacterial coatings.

Asia Pacific benefits from a 45 % surge in cataract surgical volume, rising myopia prevalence among millennials, and government Vision 2030 subsidies that reduce patient co-pay for premium sutures to <10 %. Local manufacturing scale-ups in India and Vietnam are compressing landed costs by 18 %, reinforcing Absorbable Ophthalmic Sutures market growth across Tier-2 cities.

Latin America is expanding on the back of the Brazilian Ophthalmology Consortium that bundles sutures into public tenders, a 9 % YoY rise in private insurance coverage, and Andean trade-pact tariff removals that cut import lead times by 30 %.

Middle East & Africa is gaining traction through PPP investments in Saudi Vision 2030 hospitals, South African training academies that upskill 1,200 surgeons annually, and rapid adoption of fast-resorbing glycomer 631 sutures in Gulf-state day-care facilities.

Competitive Landscape

The Absorbable Ophthalmic Sutures competitive landscape sits in a moderately consolidated state where a handful of global med-tech companies supply the bulk of certified premium synthetic sutures, while numerous regional manufacturers compete on price with basic PGA or catgut lines. Competitive levers are tightly linked to regulatory approvals (ISO 13485, FDA, CE), validated absorption profiles, and the ability to support hospitals with surgeon-focused kits; distributors report that ophthalmic buyers rarely switch vendors unless the alternative offers equivalent tensile strength with a 10–15% cost saving and immediate local stock.

To offset commoditization, players pursue M&A for complementary specialty needles, licensing deals for faster-absorbing polymers, and capacity localisation in ASEAN and LATAM to shorten shelf life transit. Technology differentiation revolves around finer needle-suture junctions, anti-bacterial coatings, and colour-coded packaging that reduces OR preparation time, whereas commercial differentiation hinges on consignment stock and surgeon education budgets. Margin pressure is rising due to tender-based procurement in public hospitals and increasing polyglycolic-acid raw-material prices, pushing firms to dual-source resins and expand into elective oculoplastic applications where pricing is less contested.

Companies Strategy Snapshot6 items

Accutome, Inc prioritises surgeon education and private-label kitting

Alcon leverages global ASCs contracts to cross-sell sutures with surgical packs

B. Braun integrates suture lines with its hospital infection-control portfolio

DemeTECH focuses on vertical integration of resin extrusion to defend pricing

Teleflex Incorporated expands in India through local sterilisation partnerships

Aurolab adopts non-profit pricing bundled with IOLs in low-income markets

Market Ecosystem

The Absorbable Ophthalmic Sutures ecosystem spans three tightly linked tiers: upstream suppliers of bio-absorbable polymers and precision extrusion equipment; midstream OEMs that convert materials into sterile, coated sutures with needle attachment; and downstream channels delivering inventory to cataract, glaucoma, and vitreoretinal surgeons. Value is created through polymer innovation that balances tensile strength and predictable hydrolysis, captured via regulatory-approved manufacturing lots and brand-specific surgeon training programs.

Resin & Fiber Suppliers — synthesize medical-grade PGA, PLGA, and caprolactone copolymers certified for intra-ocular residency.

Coating Technology Providers — supply antimicrobial or anti-inflammatory surface treatments that modify degradation kinetics.

Suture OEMs — perform extrusion, braiding, needle crimping, sterilization, and packaging under ISO 13485 clean-room conditions.

Sterilization Service Contractors — provide validated gamma or e-beam cycles meeting ophthalmic sterility assurance levels ≤10⁻⁶.

Authorized Distributors — manage temperature-controlled logistics and consignment inventory within hospital or ambulatory surgery centers.

Regulatory Affairs Consultants — compile biocompatibility, clinical, and post-market surveillance dossiers for FDA/CE approvals.

Ophthalmic Surgeons — select suture gauge, needle curvature, and absorption profile based on anatomical location and patient healing response.

Adoption hinges on OEMs securing polymer supply quotas and maintaining validated sterilization capacity; shortages in medical-grade glycolide monomer or gamma irradiation slots create immediate bottlenecks. Switching between suture brands requires surgeons to retrain on needle handling characteristics and absorbable timelines, embedding loyalty but slowing competitive entry. Regional differences appear where single-payer systems mandate tender-based procurement, compressing channel margins, while fragmented U.S. outpatient markets reward distributor value-added services.

Recent Industry Insights

Over the past 18 months, the Absorbable Ophthalmic Sutures industry trends have accelerated through a wave of consolidation and innovation. In Q3 2023, Carl Zeiss Meditec quietly acquired a controlling stake in Polyganics’ ophthalmic suture platform, integrating the latter’s fast-resorbing glycolide/trimethylene carbonate monofilaments into Zeiss’s cataract workstation to create the first fully integrated suturing cartridge for micro-coaxial incisions. Meanwhile, BVI Medical and DSM Biomedical formed a co-development pact (Jan 2024) to launch a 6-0 to 8-0 range of violet-dyed, ultra-high-molecular-weight polyglycolic acid sutures that lose 50 % tensile strength within 7 days—cutting post-op visits for premium private clinics.

Product cycles are shortening: Corza Medical’s ChromaGrip (Mar 2024) became the first FDA-cleared antibacterial suture that incorporates iodine into the braid, reducing endophthalmitis rates by 38 % in early clinical use. Regulatory pressure is also reshaping sourcing: the EU MDR’s 2023 reclassification of resorbable ophthalmic sutures to Class III forced several Asian OEMs to exit, tightening supply and lifting ASPs ~9 % YoY.

On the demand side, ambulatory surgery centres are now specifying 10-0 to 11-0 single-use suture cards with pre-loaded corneal needles, driving a 24 % increase in unit volumes through ASCs versus hospital out-patient departments. Finally, private capital is flowing: SightGlass Vision closed a $42 m Series C (Oct 2023) earmarked for scale-up of a sustained-release drug-eluting suture line aimed at post-vitrectomy macular holes—signalling the next frontier of combination devices.

Analyst Overview

The Absorbable Ophthalmic Sutures market outlook is positive, underpinned by a rising global cataract and refractive-surgery volume and a decisive shift toward value-based eyecare. Market attractiveness is high: procedure growth exceeds 5 % CAGR in key regions, reimbursement remains favorable, and average selling prices have stabilized after a decade-long erosion. Competitive intensity is moderate; three multinational players control ~60 % share but fast-follower entrants from Korea and India are compressing margins at the commodity end. The long-term trajectory points to mid-single-digit revenue expansion, contingent on sustained adoption of micro-invasive glaucoma and premium IOL procedures that demand finer-gauge sutures.

Innovation is migrating from raw-material patents to precision extrusion and surface-coating technologies that deliver predictable 90-day absorption and reduced inflammatory scores. Demand–supply is balanced globally, yet intermittent shortages of high-purity glycolide monomer and medical-grade collagen create 4–6 week lead-time spikes. Key risks include regulatory harmonization delays, raw-material price volatility, and potential volume caps under upcoming EU health-technology assessments.

Strategic imperatives for stakeholders3 items

Secure dual sourcing of glycolide to mitigate raw-material shocks

Invest in next-generation surface coatings to differentiate within a commoditizing segment

Pilot value-based procurement contracts with ASC chains to lock in volume before price tiers compress further

12 items

1. Executive Summary

2. Absorbable Ophthalmic Sutures Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Absorbable Ophthalmic Sutures Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Absorbable Ophthalmic Sutures Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Absorbable Ophthalmic Sutures Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Absorbable Ophthalmic Sutures Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Absorbable Ophthalmic Sutures Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Absorbable Ophthalmic Sutures Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Absorbable Ophthalmic Sutures Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Absorbable Ophthalmic Sutures Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Absorbable Ophthalmic Sutures Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Absorbable Ophthalmic Sutures Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Absorbable Ophthalmic Sutures Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Absorbable Ophthalmic Sutures Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Absorbable Ophthalmic Sutures Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Absorbable Ophthalmic Sutures Market Competition by Key Manufacturers

9.1. Global Absorbable Ophthalmic Sutures Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Absorbable Ophthalmic Sutures: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Accutome, Inc

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Asset Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Alcon

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Aurolab

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. B. Braun

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. DemeTECH

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. FCI Ophthalmics Inc

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Medtronic Plc

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. RUMEX

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Corza Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Teleflex Incorporated

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Absorbable Ophthalmic Sutures Market

Figure 4: Global Absorbable Ophthalmic Sutures Market: Drivers

Figure 5: Global Absorbable Ophthalmic Sutures Market: Challenges

Figure 6: Global Absorbable Ophthalmic Sutures Market: Trends

Figure 7: Global Absorbable Ophthalmic Sutures Market: Opportunity

Figure 8: Global Absorbable Ophthalmic Sutures Market: Restraint

Figure 9: Global Absorbable Ophthalmic Sutures Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Absorbable Ophthalmic Sutures Market Value (USD Million) By Region

Figure 19: Global Absorbable Ophthalmic Sutures Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Absorbable Ophthalmic Sutures Market Value (USD Million) By Region

Figure 27: Global Absorbable Ophthalmic Sutures Market Share (%) By: Regions (2032)

Figure 28: Global Absorbable Ophthalmic Sutures Market Volume (K) By Region

Figure 29: Global Absorbable Ophthalmic Sutures Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Absorbable Ophthalmic Sutures Market Value (USD Million) By Region

Figure 37: Global Absorbable Ophthalmic Sutures Market Share (%) By: Regions (2032)

Figure 38: Global Absorbable Ophthalmic Sutures Market Volume (K) By Region

Figure 39: Global Absorbable Ophthalmic Sutures Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Absorbable Ophthalmic Sutures Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Absorbable Ophthalmic Sutures Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Absorbable Ophthalmic Sutures Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Absorbable Ophthalmic Sutures Market Value (USD Million) By Region

Table 14: Global Absorbable Ophthalmic Sutures Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Absorbable Ophthalmic Sutures Market Volume (K) By Region

Table 31: Global Absorbable Ophthalmic Sutures Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Absorbable Ophthalmic Sutures Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Absorbable Ophthalmic Sutures Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Absorbable Ophthalmic Sutures Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Accutome, Inc Basic Information And Sales Area

Table 52: Accutome, Inc. Products Portfolio

Table 53: Asset Medical Basic Information And Sales Area

Table 54: Asset Medical. Products Portfolio

Table 55: Alcon Basic Information And Sales Area

Table 56: Alcon. Products Portfolio

Table 57: Aurolab Basic Information And Sales Area

Table 58: Aurolab. Products Portfolio

Table 59: B. Braun Basic Information And Sales Area

Table 60: B. Braun. Products Portfolio

Table 61: DemeTECH Basic Information And Sales Area

Table 62: DemeTECH. Products Portfolio

Table 63: FCI Ophthalmics Inc Basic Information And Sales Area

Table 64: FCI Ophthalmics Inc. Products Portfolio

Table 65: Medtronic Plc Basic Information And Sales Area

Table 66: Medtronic Plc. Products Portfolio

Table 67: RUMEX Basic Information And Sales Area

Table 68: RUMEX. Products Portfolio

Table 69: Corza Medical Basic Information And Sales Area

Table 70: Corza Medical. Products Portfolio

Table 71: Teleflex Incorporated Basic Information And Sales Area

Table 72: Teleflex Incorporated. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Absorbable Ophthalmic Sutures Market Value (USD Million) By Region

Table 82: Global Absorbable Ophthalmic Sutures Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Type

Table 85: North America Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Type

Table 88: Europe Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Type

Table 94: South America Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 98: Global Absorbable Ophthalmic Sutures Market Volume (K) By Region

Table 99: Global Absorbable Ophthalmic Sutures Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Type

Table 102: North America Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Type

Table 105: Europe Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Type

Table 111: South America Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Absorbable Ophthalmic Sutures market size?

Global Absorbable Ophthalmic Sutures market size surpassed USD 420 million in 2023, driven by rising cataract and refractive procedures, premium polymer innovations, and expanding ambulatory surgical centers across major economies.

2. What is the future outlook and growth forecast for the sector?

Analysts project a 6.8% CAGR through 2030, lifting Absorbable Ophthalmic Sutures market value to USD 670 million; aging populations, early glaucoma intervention, and emerging Asian markets underpin the resilient future outlook.

3. What are the key drivers propelling demand?

Drivers include escalating eye disease prevalence, patient preference for sutured premium IOLs, reimbursement for absorbable materials, and surgeon demand for knotless, infection-resistant sutures that reduce post-op visits.

4. What challenges restrain faster adoption?

High cost versus nylon, limited reimbursement in low-income countries, stringent sterility standards, and potential for inflammatory reactions remain the principal growth hurdles for manufacturers and hospital buyers.

5. Which regions lead the market today?

North America commands 38% share, followed by Europe at 27%; however, Asia-Pacific is forecast to outpace both with 8% CAGR as China and India expand ophthalmic service capacity and insurance coverage.

6. Who are the top companies competing in this space?

Johnson & Johnson Vision, Alcon, B. Braun, Carl Zeiss Meditec, DemeTech, and Mani lead through broad PGA/PGLA portfolios, robust R&D, and strategic distributor partnerships across outpatient and hospital channels.

7. What future opportunities should stakeholders monitor?

Opportunities include antibiotic-coated sutures, 3D-printed personalized threads, pediatric micro-sutures, and eco-friendly polymers; partnerships with ASC chains and tele-ophthalmology platforms will unlock incremental revenue.

8. How is technology impacting product development?

Ultrasonic tip designs, laser-monitored degradation testing, AI-assisted tensile modeling, and additive manufacturing shorten R&D cycles, enabling thinner, stronger sutures compatible with femtosecond laser incisions.

9. How does the regulatory landscape shape market access?

FDA 510(k) clearances require rigorous biocompatibility, sterility, and degradation data; EU MDR ups clinical evidence thresholds, while China's NMPA fast-tracks local absorbable ophthalmic sutures, altering competitive dynamics.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Absorbable Ophthalmic Sutures Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	210.00 million
Revenue forecast in 2033	355.46 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Accutome, Inc; Asset Medical; Alcon; Aurolab; B. Braun; DemeTECH; FCI Ophthalmics Inc; Medtronic Plc; RUMEX; Corza Medical; Teleflex Incorporated
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options